neurostimulation

The European Society for Brain Stimulation opposes EU reclassification of TMS and tDCS, claiming a flawed safety assessment

by Leave a Comment

Man­i­festo: Oppo­si­tion to EU Reclas­si­fi­ca­tion of TMS and tDCS equip­ment to Class III devices based on flawed evi­dence (Euro­pean Soci­ety for Brain Stimulation):

It has recent­ly come to our atten­tion that the EU has reclas­si­fied the NIBS equip­ments includ­ing rTMS and tDCS, as Class III devices, the cat­e­go­ry of high­est risk, sim­i­lar to inva­sive treat­ments, such as deep-brain stim­u­la­tion implants. This reclas­si­fi­ca­tion has a major impact on our field, not only for man­u­fac­tur­ers, but also for researchers, clin­i­cians and patients and we judge this reclas­si­fi­ca­tion a mis­take. First, the evi­den­tial basis for this change is a flawed assess­ment of the safe­ty lit­er­a­ture. Sec­ond, the con­sul­ta­tion process has occurred with­out input from spe­cial­ists or stake­hold­ers pro­fes­sion­al­ly active in the field of NIBS. Nei­ther the ESBS nor Nation­al Soci­eties of Brain Stim­u­la­tion nor indi­vid­ual experts with­in the Euro­pean NIBS com­mu­ni­ty were con­sult­ed on this change. [Read more…] about The Euro­pean Soci­ety for Brain Stim­u­la­tion oppos­es EU reclas­si­fi­ca­tion of TMS and tDCS, claim­ing a flawed safe­ty assessment

Neurostimulation device GammaSense by Cognito Therapeutics secures FDA Breakthrough Device Designation to explore Alzheimer’s Disease applications

by

Cred­it: The Picow­er Insti­tute @ MIT

Cog­ni­to Ther­a­peu­tics nets FDA break­through label for light, sound ther­a­py for Alzheimer’s dis­ease (Fierce Biotech):

Using spe­cif­ic fre­quen­cies of flash­ing lights and sounds to stim­u­late the brain’s elec­tri­cal activ­i­ty, Cog­ni­to Ther­a­peu­tics believes it can help treat Alzheimer’s dis­ease by ener­giz­ing neu­rons and reac­ti­vat­ing the immune system.

[Read more…] about Neu­rostim­u­la­tion device Gam­maSense by Cog­ni­to Ther­a­peu­tics secures FDA Break­through Device Des­ig­na­tion to explore Alzheimer’s Dis­ease applications

Update: Moderate lifetime drinking may lead to lower Alzheimer-related beta amyloid deposits in the brain

by

__

Time for a new edi­tion of Sharp­Brains’ e‑newsletter.

#1. First of all, it’s not all bad news this month. Study finds that mod­er­ate life­time drink­ing may lead to low­er Alzheimer-relat­ed beta amy­loid deposits in the brain

#2. And, talk about per­son­al­ized med­i­cine! This fas­ci­nat­ing study show­ing how brain imag­ing (fMRI) + machine learn­ing + inten­sive, non-inva­sive neu­rostim­u­la­tion = tar­get­ed treat­ments that can max­i­mize effi­ca­cy and min­i­mize side effects: Rein­vent­ing depres­sion treat­ment via tran­scra­nial mag­net­ic brain stim­u­la­tion (TMS)

#3. Also, not a minute too soon … Med­i­ta­tion apps have gone main­stream in the covid-19 era and Dig­i­tal health start-ups raised a record $3.1 bil­lion in Q1; focus will like­ly evolve from providers to con­sumers and employers

#4. Fyi, a very time­ly vir­tu­al event com­ing Tues­day April 28th, online: Explore strate­gies and tools to boost men­tal well­be­ing dur­ing (and after) Covid-19

#5. Now, “While Pear has an advan­tage over the com­pe­ti­tion in that its prod­ucts are backed by ran­dom­ized clin­i­cal tri­als, physi­cians and health plans are still work­ing out how to pre­scribe and pay for dig­i­tal ther­a­peu­tics.” The FDA clears Som­ryst, Pear’s dig­i­tal ther­a­peu­tic to treat chron­ic insomnia

#6. Net net, now is the time for indi­vid­ual and col­lec­tive action to shift to a health­i­er “new nor­mal” for all: 3 ways to pro­tect your men­tal health dur­ing –and after– COVID-19 (in Span­ish: Tres hábitos de higiene men­tal para vencer al COVID-19 y crear un futuro más salud­able). Want more? Enjoy these Three tips for wise minds to calm coro­n­avirus anxiety

#7. A small but impor­tant study for that hope­ful near future when uni­ver­si­ties and col­leges reopen their doors: Study finds mixed results of Adder­all as cog­ni­tive enhancer (seems to boost emo­tion more than cognition)

#8. But, first things first. “The Bee Gees song “Stayin’ Alive” reached #1 on the pop charts in 1977. Maybe it was the beat, maybe it was John Travolta’s danc­ing. Or maybe it’s that the Gibb broth­ers’ cen­tral lyric is quite lit­er­al­ly always play­ing in our head. Keep­ing us safe —that is, “stayin’ alive ”— is the pri­ma­ry mis­sion of the brain”

Enough with coro­n­avirus out­break. Any­thing else going on? Yes!

#9. The Right to Per­son­al Iden­ti­ty. The Right to Free Will. The Right to Men­tal Pri­va­cy. The Right to Equal Access to Men­tal Aug­men­ta­tion. The Right to Pro­tec­tion from Algo­rith­mic Bias. Will these five Neu­roR­ights help har­ness emerg­ing neu­rotech­nolo­gies for the com­mon good?

#10. “Today, the sci­en­tif­ic inves­ti­ga­tion of tran­scen­dent expe­ri­ences is, in my view, one of the most excit­ing fron­tiers in the sci­ence of well-being.” Tran­scend­ing Maslow’s famous “hier­ar­chy of needs” through Maslow’s own research on Peak Experiences

#11. You CAN have your cake and eat it too: Here’s a brain teas­er to stim­u­late your men­tal imagery, spa­tial rota­tion … and appetite

#12. Ques­tion: My first thought after con­grat­u­lat­ing myself on being so clever about some­thing? Tease your brain with these eight fun rid­dles…

 

Wish­ing you and yours a great month of May,

 

The Sharp­Brains Team

Halo Neuroscience raises $13M to further develop and commercialize neuromodulation headset aimed at inducing “hyperplasticity”

by

___

Halo Neu­ro­science rais­es $13m in Series B (Mass Device):

“Neu­rostim­u­la­tion device mak­er Halo Neu­ro­science said today it raised $13 mil­lion in a Series B round of financ­ing to sup­port its Halo Sport neu­rostim head­set designed to improve mus­cle mem­o­ry acqui­si­tion from ath­let­ic train­ing. [Read more…] about Halo Neu­ro­science rais­es $13M to fur­ther devel­op and com­mer­cial­ize neu­ro­mod­u­la­tion head­set aimed at induc­ing “hyper­plas­tic­i­ty”

Two Alvaros leading brain health @ BrainFutures 2017

by

– Álvaro Fer­nán­dez Ibáñez (left) and Álvaro Pas­cual-Leone (right), speak­ing yes­ter­day at Brain­Fu­tures 2017

Keynot­ing a fan­tas­tic con­fer­ence, Álvaro Pas­cual-Leone pre­sent­ed an overview of Neu­ro­mod­u­la­tion and Neu­rostim­u­la­tion, and Álvaro Fer­nán­dez Ibáñez dis­cussed the future of Brain Health and Enhance­ment build­ing on the slid­edeck below.

Excit­ing times!

Hun­dreds of sci­ence labs and com­pa­nies around the globe are research­ing and devel­op­ing new ways to help brain own­ers be smarter, sharp­er and health­i­er. What explains this flur­ry of activ­i­ty, and where may it be head­ed? Which com­pa­nies, tech­nolo­gies and solu­tions are gain­ing the most trac­tion so far, and what are some of the best prac­tices for appro­pri­ate use?

Eight research teams working with DARPA to discover best ways to activate neuroplasticity and accelerate learning

by

DARPA Funds Brain-Stim­u­la­tion Research to Speed Learn­ing (DoD news):

“The Defense Advanced Research Projects Agency is work­ing with sev­en U.S. uni­ver­si­ties and ele­ments of the Air Force and Army on research that seeks to stim­u­late the brain in a non-inva­sive way to speed up learning.

DARPA announced the Tar­get­ed Neu­ro­plas­tic­i­ty Train­ing, or TNT, pro­gram [Read more…] about Eight research teams work­ing with DARPA to dis­cov­er best ways to acti­vate neu­ro­plas­tic­i­ty and accel­er­ate learning